Claraphi Advisory Network, LLC Abb Vie Inc. Transaction History

Claraphi Advisory Network, LLC

$248 Million
Q4 2022

A detailed history of Claraphi Advisory Network, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Claraphi Advisory Network, LLC holds 3,112 shares of ABBV stock, worth $550,668. This represents 0.2% of its overall portfolio holdings.

Number of Shares

3,112

Previous 502,790 99.38%

Holding current value

$550,668

Previous $81.3 Million 99.38%

% of portfolio

0.2%

Previous 0.29%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $69.1 Million - $82.9 Million	-499,678 Reduced 99.38%	3,112 $503,000
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $69.3 Million - $83.2 Million	501,299 Added 33621.66%	502,790 $81.3 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $2.43 Million - $2.78 Million	-18,086 Reduced 92.38%	1,491 $200,000
Q2 2022 Jul 19, 2022	BUY	$137.62 - $174.96 $243,036 - $308,979	1,766 Added 9.92%	19,577 $3 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $1.06 Million - $1.31 Million	8,016 Added 81.84%	17,811 $2.89 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $77,134 - $97,597	-718 Reduced 6.83%	9,795 $1.33 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $43,624 - $49,519	-410 Reduced 3.75%	10,513 $1.13 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $68,281 - $76,069	-649 Reduced 5.61%	10,923 $1.23 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $44,193 - $48,651	432 Added 3.88%	11,572 $1.25 Million
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $174,019 - $234,944	-2,162 Reduced 16.25%	11,140 $1.19 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $287,283 - $337,175	-3,344 Reduced 20.09%	13,302 $1.17 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $379,689 - $508,081	5,175 Added 45.11%	16,646 $1.63 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $60,178 - $91,238	933 Added 8.85%	11,471 $874,000
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $24,307 - $30,414	-337 Reduced 3.1%	10,538 $933,000
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $15,745 - $18,930	-250 Reduced 2.25%	10,875 $823,000
Q2 2019 Jul 29, 2019	BUY	$65.7 - $83.98 $82,979 - $106,066	1,263 Added 12.81%	11,125 $809,000
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $101,670 - $119,661	1,318 Added 15.43%	9,862 $795,000
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $47,254 - $58,278	607 Added 7.65%	8,544 $787,000
Q3 2018 Nov 09, 2018	BUY	$88.91 - $98.84 $326,655 - $363,138	3,674 Added 86.18%	7,937 $751,000
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $7,721 - $9,135	-86 Reduced 1.98%	4,263 $395,000
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $65,879 - $88,218	716 Added 19.71%	4,349 $411,000
Q4 2017 Feb 05, 2018	BUY	$89.56 - $98.21 $325,371 - $356,796	3,633	3,633 $351,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.

Account

Claraphi Advisory Network, LLC Abb Vie Inc. Transaction History